SCHEMBL4334649

SCHEMBL4334649

CC(Cc1ccccn1)N1C(=O)c2ccccc2C1C(=O)NCc1ccc(OC2CCC(F)(F)CC2)nc1

nearest known ligand 0.64

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 18/20 0.64
KCNH2 Q12809 13/20 0.64
SCN5A Q14524 12/20 0.64
KCNA5 P22460 2/20 0.44
KCNQ2 O43526 1/20 0.44
SCN2A Q99250 1/20 0.44
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322617 0.85 SCN9A (0.69) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL13579072 0.84 SCN9A (0.73) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL4334652 0.83 SCN9A (0.54) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL3954655 0.79 SCN9A (0.76) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL3893189 0.79 SCN9A (0.76) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL3891943 0.79 SCN9A (0.80) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL3891906 0.78 SCN9A (1.00) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL4452741 0.76 LNPEP (0.36) SCN9AKCNH2SCN5A
SCHEMBL3963578 0.75 SCN9A (0.72) SCN9AKCNH2SCN5AKCNA5KCNQ2
SCHEMBL3959385 0.75 SCN9A (0.72) SCN9AKCNH2SCN5AKCNA5KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009145720-A1 ISOINDOLINE DERIVATIVES COMPRISING ADDITIONAL HETEROCYCLIC GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO claimed
WO-2009145720-A1 ISOINDOLINE DERIVATIVES COMPRISING ADDITIONAL HETEROCYCLIC GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed
WO-2009145720-A1 ISOINDOLINE DERIVATIVES COMPRISING ADDITIONAL HETEROCYCLIC GROUPS AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed